Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Development of protective egg yolk immunoglobulins (IgY) targeting CfaB, LTB, and EtpA recombinant proteins of Enterotoxigenic Escherichia coli (ETEC) for inhibiting toxin activity and bacterial adherence. | Braz J Microbiol | 2025 | 39500826 | PubTator, text mining | PubMed |
| Modulation of the Immunological Milieu in Acute Aneurysmal Subarachnoid Hemorrhage: The Potential Role of Monocytes Through CXCL10 Secretion. | Transl Stroke Res | 2025 | 38780865 | PubTator, text mining | PubMed |
| Prognostic model based on M2 macrophage-related signatures for predicting outcomes, enhancing risk stratification, and providing therapeutic insights in diffuse large B-cell lymphoma. | Heliyon | 2024 | 39759325 | PubTator, text mining | PubMed |
| NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer. | Breast Cancer Res | 2024 | 39623404 | PubTator, text mining | PubMed |
| Identification of a Novel Signature Based on Ferritinophagy-Related Genes to Predict Prognosis in Lung Adenocarcinoma: Focus on AHNAK2. | Bioengineering (Basel) | 2024 | 39593730 | PubTator, text mining | PubMed |
| Identifying therapeutic targets for kidney stone disease through proteome-wide Mendelian randomization and colocalization analysis. | Urolithiasis | 2024 | 39585470 | PubTator, text mining | PubMed |
| Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis. | J Transl Med | 2024 | 39472987 | PubTator, text mining | PubMed |
| scCTS: identifying the cell type-specific marker genes from population-level single-cell RNA-seq. | Genome Biol | 2024 | 39402623 | PubTator, text mining | PubMed |
| CRISPR-GEM: A Novel Machine Learning Model for CRISPR Genetic Target Discovery and Evaluation. | ACS Synth Biol | 2024 | 39375864 | PubTator, text mining | PubMed |
| VSIG4 induces the immunosuppressive microenvironment by promoting the infiltration of M2 macrophage and Tregs in clear cell renal cell carcinoma. | Int Immunopharmacol | 2024 | 39260310 | PubTator, text mining | PubMed |
| In vivo dendritic cell reprogramming for cancer immunotherapy. | Science | 2024 | 39236156 | PubTator, text mining | PubMed |
| New insights into potential biomarkers and their roles in biological processes associated with hepatitis C-related liver cirrhosis by hepatic RNA-seq-based transcriptome profiling. | Virus Res | 2024 | 39216827 | PubTator, text mining | PubMed |
| The dual roles of lymphotoxin-β in promoting breast cancer bone metastasis. | Nat Cell Biol | 2024 | 39198696 | PubTator, text mining | PubMed |
| Integrative analysis reveals novel insights into juvenile idiopathic arthritis pathogenesis and shared molecular pathways with associated traits. | Front Genet | 2024 | 39175752 | PubTator, text mining | PubMed |
| Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma. | Liver Int | 2024 | 39164890 | PubTator, text mining | PubMed |
| Lymphotoxin-β promotes breast cancer bone metastasis colonization and osteolytic outgrowth. | Nat Cell Biol | 2024 | 39147874 | PubTator, text mining | PubMed |
| Stromal cell and B cell dialogue potentiates IL-33-enriched lymphoid niches to support eosinophil recruitment and function during type 2 immunity. | Cell Rep | 2024 | 39141517 | PubTator, text mining | PubMed |
| Validation and functional follow-up of cervical cancer risk variants at the HLA locus. | HLA | 2024 | 39101335 | PubTator, text mining | PubMed |
| Integrative profiling of untreated primary membranous nephropathy at the single-cell transcriptome level. | Clin Kidney J | 2024 | 39027416 | PubTator, text mining | PubMed |
| Human yolk sac-derived innate lymphoid-biased multipotent progenitors emerge prior to hematopoietic stem cell formation. | Dev Cell | 2024 | 38996461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=5